HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$1.16
Day range
$1.13 - $1.18
Year range
$1.11 - $2.17
Market cap
19.21M USD
Avg Volume
68.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.55M | -23.65% |
Net income | -6.48M | 56.16% |
Net profit margin | — | — |
Earnings per share | -0.38 | 63.81% |
EBITDA | -6.39M | 26.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.04M | -36.79% |
Total assets | 47.13M | -31.96% |
Total liabilities | 32.99M | -0.23% |
Total equity | 14.14M | — |
Shares outstanding | 16.85M | — |
Price to book | 1.38 | — |
Return on assets | -32.80% | — |
Return on capital | -39.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.48M | 56.16% |
Cash from operations | -5.19M | 27.00% |
Cash from investing | 6.51M | -54.33% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 1.31M | 111.69% |
Free cash flow | -2.61M | 25.85% |
About
Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
19
